Kaster Deborah reported ADGM

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002089223-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Mar 6, 2026

Published

Mar 9, 2026

Ingested by INSIDER

Nov 5, 04:12 UTC

Last re-read

Nov 5, 04:12 UTC

Extracted facts

Filer

Kaster Deborah

Role

Chief Financial Officer

Transaction

Grant or awardAs filed: “A”

Asset

Adagio Medical Holdings, Inc. — Employee Stock Options (Right to Buy)

Ticker

ADGM

Shares

490.5K

Price per share

$0

Execution date (reported)

Mar 6, 2026

Owned after transaction

490.5K shares

Days from execution to publication

3

What this establishes

Kaster Deborah filed this Form 4 reporting a grant or award of ADGM on Mar 6, 2026. It became public on Mar 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Financial Officer

Kaster Deborahcik:0002089223

Issuer

Adagio Medical Holdings, Inc.cik:0002006986

Revision history · 0

No field has changed since this record was first ingested.